Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation

Liu, David S., Duong, Cuong P., Haupt, Sue, Montgomery, Karen G., House, Colin M., Azar, Walid J., Pearson, Helen B., Fisher, Oliver M. +8 more·2017·Nature Communications

DOI 10.1038/ncomms14844

Cited by (318)

Items 101–200 of 318

Glutathione in cancer progression and chemoresistance: an update
Giulia Elda Valenti, Bruno Tasso, Nicola Traverso, Cinzia Domenicotti, Barbara Marengo · 2023 · Redox Experimental Medicine
Ferroptosis and Cancer: Complex Relationship and Potential Application of Exosomes
Shuang Wu, Tianye Li, Weiwei Liu, Yongye Huang · 2021 · Frontiers in Cell and Developmental Biology
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
Salih Demir, Elena Boldrin, Qian Sun, Stephanie Hampp, Eugen Tausch, Cornelia Eckert, Martin Ebinger, Rupert Handgretinger, Geertruy te Kronnie, Lisa Wiesmüller et al. · 2019 · Haematologica
Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target
Shaohua Ma, Chorlada Paiboonrungruan, Tiansheng Yan, Kevin P. Williams, Michael B. Major, Xiaoxin Luke Chen · 2018 · Annals of the New York Academy of Sciences
From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
Éric Grignano, Rudy Birsen, Nicolas Chapuis, Didier Bouscary · 2020 · Frontiers in Oncology
The relevant targets of anti-oxidative stress: a review
Jianhong Qi, Fang-xu Dong · 2021 · Journal of drug targeting
Cold Atmospheric Plasma Increases Temozolomide Sensitivity of Three-Dimensional Glioblastoma Spheroids via Oxidative Stress-Mediated DNA Damage
Priyanka Shaw, Naresh Kumar, Angela Privat‐Maldonado, Evelien Smits, Annemie Bogaerts · 2021 · Cancers
Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
Paola Menichini, Paola Monti, Andrea Speciale, Giovanna Cutrona, Serena Matis, Franco Fais, Elisa Taìana, Antonino Neri, Riccardo Bomben, Massimo Gentile et al. · 2021 · Cells
Sinapine induced ferroptosis in non-small cell lung cancer cells by upregulating transferrin/transferrin receptor and downregulating SLC7A11
Min Shao, Qi Jiang, Chao Shen, Zhong Liu, Lihong Qiu · 2022 · Gene
BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells
Diane Moujalled, Adam G. Southon, Eiman Saleh, Kerstin Brinkmann, Francine Ke, Melinda Iliopoulos, Ryan Stanley Cross, Misty Rayna Jenkins, Duong Nhu, Zilu Wang et al. · 2022 · Cell Death and Differentiation
The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
Po-Han Chen, Watson Hua-Sheng Tseng, J. Chi · 2020 · Biology
Glutaredoxin attenuates glutathione levels via deglutathionylation of Otub1 and subsequent destabilization of system xC−
Reem Aboushousha, Jos L. J. van der Velden, Nicholas Hamilton, Zhihua Peng, Maximilian B. MacPherson, Cuixia Shi Erickson, Sheryl L. White, Emiel F.�M. Wouters, Niki L. Reynaert, David Joseph Seward et al. · 2023 · Science Advances
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation Status
Fujihara, Kenji M., Corrales Benitez, Mariana, Cabalag, Carlos S., Zhang, Bonnie Z., Ko, Hyun S., Liu, David S., Simpson, Kaylene J., Haupt, Ygal, Lipton, Lara, Haupt, Sue et al. · 2021 · Molecular Cancer Therapeutics
p53 and Zinc: A Malleable Relationship
Jeung‐Hoi Ha, Orjola Prela, Darren R. Carpizo, Stewart N. Loh · 2022 · Frontiers in Molecular Biosciences
Ferroptosis and Its Emerging Role in Pre-Eclampsia
Zhixian Chen, Jianfeng Gan, Mo Zhang, Yan Du, Hongbo Zhao · 2022 · Antioxidants
Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy
Małgorzata Firczuk, Małgorzata Bajor, Agnieszka Graczyk‐Jarzynka, Klaudyna Fidyt, Agnieszka Góral, Radosław Zagożdżon · 2019 · Cancer Letters
Small-molecule correctors and stabilizers to target p53
Fallatah, Maryam M.J., Law, Fiona V., Chow, Warren A., Kaiser, Peter · 2023 · Trends in Pharmacological Sciences
Molecular mechanisms of ferroptosis and its role in prostate cancer therapy
Shaokun Wang, Wei Wei, Ning Ma, Yongliang Qu, Qiuju Liu · 2022 · Critical Reviews in Oncology/Hematology
Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology
Maria Concetta Scuto, Angela Trovato Salinaro, Isabella Caligiuri, Maria Laura Ontario, Valentina Greco, Nello Sciuto, Roberto Crea, Edward J. Calabrese, Flavio Rizzolio, Vincenzo Canzonieri et al. · 2021 · Mechanisms of Ageing and Development
Distinct TP53 Mutation Types Exhibit Increased Sensitivity to Ferroptosis Independently of Changes in Iron Regulatory Protein Activity
Laurie R. Thompson, Thais Gaia Oliveira, Evan R. Hermann, Winyoo Chowanadisai, Stephen L. Clarke, McKale R. Montgomery · 2020 · International Journal of Molecular Sciences
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death
Ceder, Sophia, Eriksson, Sofi E, Cheteh, Emarndeena H, Dawar, Swati, Corrales Benitez, Mariana, Bykov, Vladimir J N, Fujihara, Kenji M, Grandin, Mélodie, Li, Xiaodun, Ramm, Susanne et al. · 2021 · EMBO Molecular Medicine
The amino acid transporter SLC7A11 expression in breast cancer
Preyanka Nath, Lutfi H. Alfarsi, Rokaya El Ansari, Brendah K. Masisi, Busra Erkan, Ali Fakroun, Ian Ogilvie Ellis, Emad A. Rakha, Andrew R. Green · 2023 · Cancer Biology & Therapy
A review on ferroptosis and photodynamic therapy synergism: Enhancing anticancer treatment
Qihang Chang, Peiru Wang, Qingyu Zeng, Xiuli Wang · 2024 · Heliyon
Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms
Xiangyu Wang, Jianhua Yang, Wanting Yang, Haiyang Sheng, Buyun Jia, Cheng Peng, Shanshan Xu, Xinhui Hong, Chuanwei Jiang, Yinfeng Yang et al. · 2024 · Journal of Advanced Research
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53
Satish Kumar Ramraj, Sugantha Priya Elayapillai, Richard C. Pelikan, Yan Daniel Zhao, Zitha Redempta Isingizwe, Amy L. Kennedy, Stanley A. Lightfoot, Doris M. Benbrook · 2019 · International Journal of Cancer
From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma
Ravindran Caspa Gokulan, Monica Tulia Garcia-Buitrago, Alexander I. Zaika · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
A self-amplified ferroptosis nanoagent that inhibits the tumor upstream glutathione synthesis to reverse cancer chemoresistance
Chuang Yang, Zheng Chen, Min Wei, Shen Hu, Mengyuan Cai, Nan Wang, Yunan Guan, Fangyuan Li, Qiang Ding, Daishun Ling · 2023 · Journal of Controlled Release
Disrupting the Redox Balance with a Diselenide Drug Delivery System: Synergistic or Antagonistic?
Yeon Su Choi, Kang Moo Huh, Min Suk Shim, In Suh Park, Yong‐Yeon Cho, Joo Young Lee, Hye Suk Lee, Han Chang Kang · 2020 · Advanced Functional Materials
Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
Jianyao Lou, Yunxiang Zhou, Zengyu Feng, Mindi Ma, Yihan Yao, Yali Wang, Yongchuan Deng, Yulian Wu · 2021 · Frontiers in Oncology
The dual role of p62 in ferroptosis of glioblastoma according to p53 status
Fanen Yuan, Qian Sun, Si Zhang, Liguo Ye, Yang Xu, Gang Deng, Zhou Xu, Shenqi Zhang, Baohui Liu, Qianxue Chen · 2022 · Cell & Bioscience
Novel analogs of sulfasalazine as system xc− antiporter inhibitors: Insights from the molecular modeling studies
Dhaval Patel, Prashant S. Kharkar, Neha S. Gandhi, Ekjot Kaur, Shilpee Dutt, Mukesh Nandave · 2019 · Drug Development Research
Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia
Hiroki Akiyama, Bing Z. Carter, Michael Andreeff, Jo Ishizawa · 2023 · Cells
A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy
Jing Yang, Wei Xiong, Lin Huang, Zongheng Li, Qingdeng Fan, Fang Hu, Xiaopin Duan, Jun‐Bing Fan, Bo Li, Jie Feng et al. · 2024 · Journal of Nanobiotechnology
Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway
Weilin Liao, Ren Zhang, Geer Chen, Xiaoyu Zhu, Weiyu Wu, Ziyu Chen, Chenyu Jiang, Zicong Lin, Lijuan Ma, Haijie Yu · 2024 · Biomedicine & Pharmacotherapy
Alterations in System xc− Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2
Raul Carpi-Santos, Karin da Costa Calaza · 2018 · Molecular Neurobiology
Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy
Ying Hou, Heng Wang, Jiarui Wu, Hongwei Guo, Xiuping Chen · 2024 · Medicinal Research Reviews
The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells
Synnott, Naoise C., Madden, Stephen F., Bykov, Vladimir J.N., Crown, John, Wiman, Klas G., Duffy, Michael J. · 2018 · Translational Oncology
Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
Jing Cai, Xiaoding Xu, Phei Er Saw · 2023 · Science China Life Sciences
A guide to ferroptosis in cancer
Fatma Isil Yapici, Christina M. Bebber, Silvia von Karstedt · 2024 · Molecular Oncology
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation
Teruyuki Kobayashi, Tomoki Makino, Kotaro Yamashita, Takuro Saito, Koji Tanaka, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Kiyokazu Nakajima, Eiichi Morii et al. · 2021 · British Journal of Cancer
Physical plasma-derived oxidants sensitize pancreatic cancer cells to ferroptotic cell death
Naresh Kumar, Claudina Angela Perez-Novo, Priyanka Shaw, Emilie Logie, Angela Privat‐Maldonado, Sylvia Dewilde, Evelien Smits, Wim Vanden Berghe, Annemie Bogaerts · 2021 · Free Radical Biology and Medicine
Physiological Effects of Ferroptosis on Organ Fibrosis
X. Du, Rui Dong, Yuzhang Wu, Bing Ni · 2022 · Oxidative Medicine and Cellular Longevity
Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells
Tessoulin, Benoit, Descamps, Geraldine, Dousset, Christelle, Amiot, Martine, Pellat-Deceunynck, Catherine · 2019 · Frontiers in Oncology
Aberrant amino acid metabolism promotes neurovascular reactivity in rosacea
Tangxiele Liu, Wenqin Xiao, Mengting Chen, Rui Mao, San Xu, Qinqin Peng, Zhixiang Zhao, Qian Wang, Hongfu Xie, Zhili Deng et al. · 2022 · JCI Insight
The role of ferroptosis in esophageal cancer
Zimin Wang, Sikai Wu, Chengchu Zhu, Jianfei Shen · 2022 · Cancer Cell International
Connecting the mechanisms of tumor sex differences with cancer therapy
Huan Li, Weibo Jiang, Shui Liu, Manshi Yang, Siyuan Chen, Yihan Pan, Mengying Cui · 2023 · Molecular and Cellular Biochemistry
Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine
Daiha Shin, Jaewang Lee, Jong‐Lyel Roh · 2024 · Cancer Letters
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Oleg N. Timofeev, Boris Klimovich, Jean Schneikert, Michael Wanzel, Evangelos Pavlakis, Julia Noll, Samet Mutlu, Sabrina Elmshäuser, Andrea Nist, Marco Mernberger et al. · 2019 · The EMBO Journal
Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53
Stewart N. Loh · 2020 · Biomolecules
The Development of p53-Targeted Therapies for Human Cancers
Yier Lu, Meng Yin Wu, Yang Xu, Lili Yu · 2023 · Cancers
Ginsenoside compound K alleviates brain aging by inhibiting ferroptosis through modulation of the ASK1-MKK7-JNK signaling pathway
Xiaojun Yan, Xue Bai, Guanghui Sun, Zhiguang Duan, Rongzhan Fu, Wen Zeng, Chenhui Zhu, Daidi Fan · 2024 · Phytomedicine
Involvement of Glutathione Depletion in Selective Cytotoxicity of Oridonin to p53-Mutant Esophageal Squamous Carcinoma Cells
Yinchao Li, Nana Li, Jianxiang Shi, Tanzeel Ahmed, Hong‐Min Liu, Jiancheng Guo, Wenxue Tang, Yongjun Guo, Qi Zhang · 2020 · Frontiers in Oncology
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies
Jolanda Magri, Alessandro Gasparetto, Laura Conti, Enzo Calautti, Chiara Cossu, Roberto Ruiu, Giuseppina Barutello, Federica Cavallo · 2021 · Cells
A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism
Ilir Sheraj, Tülïn Güray, Sreeparna Banerjee · 2021 · Scientific Reports
Discovery of compounds that reactivate p53 mutants in vitro and in vivo
Geetha Durairaj, Özlem Demir, Bryant Lim, Roberta Baronio, Delia F. Tifrea, Linda Hall, Jacob C. DeForest, Linda Lauinger, Maryam M.J. Fallatah, Clinton Yu et al. · 2022 · Cell chemical biology
Catabolism of extracellular glutathione supplies cysteine to support tumours
Fábio Hecht, Marco Zocchi, Emily T. Tuttle, Nathan P. Ward, Fatemeh Alimohammadi, A. M. Zakaria Khan, Veronica C. Gomes, Bradley Smith, Jennifer J. Twardowski, Bradley N. Mills et al. · 2026 · Nature
Current insights into the regulation of programmed cell death by TP53 mutation in cancer
Yali Su, Yingying Sai, Linfeng Zhou, Zeliang Liu, Panyan Du, Jinghua Wu, Jinghua Zhang · 2022 · Frontiers in Oncology
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells
Margalida Torrens‐Mas, Marco Cordani, Nidula Mullappilly, Raffaella Pacchiana, Chiara Riganti, Marta Palmieri, Daniel Gabriel Pons, Pilar Roca, Jordi Oliver, Massimo Donadelli · 2019 · Archives of Biochemistry and Biophysics
Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer
Monika Raab, Izabela Kostova, Samuel Peña‐Llopis, Daniela Fietz, Monika Kressin, Seyed Mohsen Aberoumandi, Evelyn Ullrich, Sven Becker, Mourad Sanhaji, Klaus Strebhardt · 2023 · 癌症：英文版
Enhancing Therapeutic Approaches in Glioblastoma with Pro-Oxidant Treatments and Synergistic Combinations: In Vitro Experience of Doxorubicin and Photodynamic Therapy
Bruno Agustín Cesca, Matías Daniel Caverzán, María Julia Lamberti, Luis Exequiel Ibarra · 2024 · International Journal of Molecular Sciences
Therapeutic Strategies to Activate p53
Angelo Aguilar, Shaomeng Wang · 2022 · Pharmaceuticals
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers
Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Christophe Hermans, Céline Merlin, Ho Wa Lau, Elly Marcq, Marlies Verschuuren, Winnok Harald De Vos, Filip Lardon et al. · 2023 · Antioxidants
p53 regulates CD46 expression and measles virus infection in myeloma cells
Anne Lok, Géraldine Descamps, Benoît Tessoulin, David Chiron, Marion Eveillard, Catherine Godon, Yannick Le Bris, Astrid Vabret, Céline Bellanger, Laurent Maillet et al. · 2018 · Blood Advances
The deubiquitinase ZRANB1 is an E3 ubiquitin ligase for SLC7A11 and regulates ferroptotic resistance
Shan Huang, Qi-Min Zhang, Manyu Zhao, Xing Wang, Yilei Zhang, Boyi Gan, Peijing Zhang · 2023 · The Journal of Cell Biology
Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression
Ann-Kathrin Eichelmann, George C. Mayne, Karen Chiam, Steven L. Due, Isabell Bastian, Frederike Butz, Tingting Wang, Pamela J. Sykes, Nicholas James Clemons, David S. Liu et al. · 2021 · International Journal of Molecular Sciences
Macrophage-mediated immune response aggravates hearing disfunction caused by the disorder of mitochondrial dynamics in cochlear hair cells
Yuan Zhang, Xiaolong Fu, Yiyuan Li, Wen Li, Guodong Hong, Siwei Guo, Yu Xiao, Ziyi Liu, Shuqin Ding, Xiuli Bi et al. · 2022 · Human Molecular Genetics
Cashing in on ferroptosis against tumor cells: Usher in the next chapter
Mehdi Rabiee Valashedi, Nima Najafi-Ghalehlou, Amirsadegh Nikoo, Chia Bamshad, Kazuo Tomita, Yoshikazu Kuwahara, Tomoaki Sato, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar · 2021 · Life Sciences
Small-Molecule NSC59984 Induces Mutant p53 Degradation through a ROS-ERK2-MDM2 Axis in Cancer Cells
Shengliang Zhang, Lanlan Zhou, Wafik S. El‐Deiry · 2022 · Molecular Cancer Research
Multiparametric High-Content Cell Painting Identifies Copper Ionophores as Selective Modulators of Esophageal Cancer Phenotypes
Rebecca E. Hughes, Richard J. R. Elliott, Xiaodun Li, Alison F. Munro, Ashraff Makda, Roderick N. Carter, Nicholas M. Morton, Kenji Mark Fujihara, Nicholas James Clemons, Rebecca Claire Fitzgerald et al. · 2022 · ACS Chemical Biology
Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function
Shawn J. Macha, Balakrishna Koneru, Trevor A. Burrow, Charles Zhu, Dzmitry Savitski, Rakhshanda Layeequr Rahman, Catherine A. Ronaghan, Jonas Nance, Kristyn McCoy, Cody R. Eslinger et al. · 2022 · Cancer Research
Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)
Shuangli Xu, Xuewei Li, Yanqiang Wang · 2023 · Experimental and Therapeutic Medicine
Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid‐induced DNA damage
Jeffrey Molendijk, Cathryn M. Kolka, Henry Cairns, Sandra Brosda, Ahmed Mohamed, Alok Kishorkumar Shah, Ian Brown, Mark P. Hodson, Thomas Hennessy, Guanghao Liu et al. · 2022 · Clinical and Translational Medicine
Fuzheng Nizeng Decoction regulated ferroptosis and endoplasmic reticulum stress in the treatment of gastric precancerous lesions: A mechanistic study based on metabolomics coupled with transcriptomics
Yingming Chu, Tingxin Wang, Xiao-Fen Jia, Yao Yang, Zongming Shi, Guanghui Cui, Qiuyue Huang, Hui Ye, Xuezhi Zhang · 2022 · Frontiers in Pharmacology
NSAID celecoxib: a potent mitochondrial pro-oxidant cytotoxic agent sensitizing metastatic cancers and cancer stem cells to chemotherapy
Stephen John Ralph, Sam Nozuhur, Rafael Moreno‐Sánchez, Sara Rodr��guez Enr��quez, Rhys Pritchard · 2018 · Journal of Cancer Metastasis and Treatment
Alternative approaches to overcome chemoresistance to apoptosis in cancer
Swapnaa Balaji, David Terrero, Amit Kumar Tiwari, Charles R. Ashby, Dayanidhi Raman · 2021 · Advances in protein chemistry and structural biology
Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity
Mohammed Z.K. Al-Hayali, Aimie E. Garces, Michael J. Stocks, Hilary M. Collins, Tracey Dawn Bradshaw · 2021 · Molecules
Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
Sue Haupt, Ygal Haupt · 2021 · Frontiers in Genetics
Trifluridine/tipiracil induces ferroptosis by targeting p53 via the p53-SLC7A11 axis in colorectal cancer 3D organoids
Maosen Huang, Yancen Wu, Xiaoxia Wei, Linyao Cheng, Lihua Fu, Haochao Yan, Wene Wei, Bo Li, Haiming Ru, Xianwei Mo et al. · 2025 · Cell Death and Disease
Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in Colorectal Cancer
Nicholas Lyons, Rabina Giri, Jakob Begun, David A. Clark, David M. Proud, Yaowu He, John David Hooper, Thomas Kryza · 2023 · Antioxidants and Redox Signaling
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy
Jaewang Lee, Jong‐Lyel Roh · 2023 · Cellular Oncology
Caspase-2 protects against ferroptotic cell death
Swati Dawar, Mariana Corrales Benitez, Yoon Pin Lim, Toby A. Dite, Jumana M. Yousef, Niko Thio, Sylvain Garciaz, Thomas Daniel Jackson, Julia V. Milne, Laura F. Dagley et al. · 2024 · Cell Death and Disease
Partial p53 reactivation is sufficient to induce cancer regression
Boris Klimovich, Laura Meyer, Nastasja Merle, Michelle M. Neumann, Alexander Marc König, Nikolaos Ananikidis, Corinna Ulrike Keber, Sabrina Elmshäuser, Oleg N. Timofeev, Thorsten Stiewe · 2022 · Journal of Experimental & Clinical Cancer Research
Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma
Jiasi Zhang, Yuxi Liu, Liping Zuo, Fengjuan Fan, Han Yan, Fei Zhao, Junying Li, Chi Ma, Qun Li, Aoshuang Xu et al. · 2024 · Blood Advances
Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management?
Marco Corazzari, Licio Collavin · 2023 · Frontiers in Genetics
P53 at the start of the 21st century: lessons from elephants
Sue Haupt, Ygal Haupt · 2017 · F1000Research
Modulation of Ferroptosis by microRNAs in Human Cancer
Irena Velkova, Martina Pasino, Zumama Khalid, Paola Menichini, Emanuele Martorana, Alberto Izzotti, Alessandra Pulliero · 2023 · Journal of Personalized Medicine
Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4
Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita, Julian Aldana, Giuseppe Carota, Mariarita Spampinato, Burak Soysal, Ilaria Cosentini, Sameer Parashar, Anuvrat Sircar et al. · 2023 · Metabolism
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
Roberta Veglia Tranchese, Sabrina Battista, Laura Cerchia, Monica Fedele · 2024 · Biomolecules
Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives
Marwan Kwok, Angelo Agathanggelou, Nicholas Davies, Tatjana Stanković · 2021 · Cancers
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
Ceder, Sophia, Eriksson, Sofi E., Liang, Ying Yu, Cheteh, Emarndeena H., Zhang, Si Min, Fujihara, Kenji M., Bianchi, Julie, Bykov, Vladimir J. N., Abrahmsen, Lars, Clemons, Nicholas J. et al. · 2021 · Cell Death & Disease
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs
Bolong Xu, Ayitila Maimaitijiang, Dawuti Nuerbiyamu, Zhengding Su, Wenfang Li · 2025 · Biomolecules
Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
Jing Yang, Zhaowei Gu · 2024 · Frontiers in Pharmacology
Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug design
Xinyu Zhang, Adnan A. Elfarra · 2018 · Expert Opinion on Drug Discovery
Rely on Each Other: DNA Binding Cooperativity Shapes p53 Functions in Tumor Suppression and Cancer Therapy
Oleg N. Timofeev, Thorsten Stiewe · 2021 · Cancers
Overview of the multifaceted resistances toward EGFR-TKIs and new chemotherapeutic strategies in non-small cell lung cancer
Rashidi Dzul Keflee, Kok Hoong Leong, Satoshi Ogawa, Jerome S. Bignon, Mun Chiang Chan, Kin Weng Kong · 2022 · Biochemical Pharmacology
Identification of two novel ferroptosis-associated targets in sepsis-induced cardiac injury: Hmox1 and Slc7a11
Yushun Xu, Gang Bu · 2023 · Frontiers in Cardiovascular Medicine
Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
Boris Klimovich, Samet Mutlu, Jean Schneikert, Sabrina Elmshäuser, Maria Klimovich, Andrea Nist, Marco Mernberger, Oleg N. Timofeev, Thorsten Stiewe · 2019 · Proceedings of the National Academy of Sciences
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas
Guillaume Beinse, Pierre‐Alexandre Just, Bastien Rance, Brigitte Izac, Franck Letourneur, Nathaniel Edward Bennett Saidu, Sandrine Chouzenoux, Carole Nicco, François Goldwasser, Éric Pasmant et al. · 2019 · PLoS ONE
Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects
Jing Zeng, Xianghong Zhang, Zhengjun Lin, Yu Zhang, Jing Yang, Pengcheng Dou, Tang Liu · 2024 · Experimental Hematology and Oncology
Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer
Mengqi Liu, Wensheng Liu, Yi Qin, Xiaowu Xu, Xianjun Yu, Qifeng Zhuo, Shunrong Ji · 2020 · Experimental Hematology and Oncology